STATEMENT FROM RANDOX: 13 September 2020

Randox analyse samples and provide Covid-19  test results through the national portal as efficiently as possible, and those tested will receive their results by text and email.    The vast majority of those tested will receive negative or positive results.

Otherwise, a small minority of samples may be voided for reasons such as leaking or damaged tubes, or have time expired.  Those being tested are made aware that samples only remain valid for a limited period once collected, and those periods of validity are fully understood across the planning and logistic process. Randox have no responsibility for the logistics of sample delivery to laboratories.

Should samples enter the laboratory outside that period the results could not be relied upon; the sample could give a false result and would be voided.  In all void circumstances individuals are advised by the national program to seek a retest.  Randox, and the Government planners, take every precaution possible to minimise voids, understanding that each sample is of critical importance.

A test can only be voided once it is processed and reviewed within our laboratory system, including cross referencing each barcode electronically with the national registration database.

Randox Laboratories are committed to supporting the Government’s response to the Covid-19 pandemic and play an important role in national network of Pillar 2 (outside the NHS) laboratories testing those who may be currently infected with Covid-19.  Such testing is critical to the timely identification and containment of Covid-19 outbreaks and to reduce further spread.   It is acknowledged that the success of the testing program is essential to the social and economic well-being of the nation.

To support our operations Randox liaise very closely with Government planners responsible for the national collection and distribution of samples, and have built an additional 30,000 square feet of laboratory space and employed many more staff in order to increase capacity.  At the time of writing further increases in capacity are being implemented and planned.  Decisions on sample distribution across the Pillar 2 laboratory network are made at a national level.

Randox remain committed to effective and timely Covid-19 testing at scale –  this is work of national importance.

Press enquiries should be emailed to randox@newcenturymedia.co.uk